TA
BMY icon

Thor Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Thor Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$20K Buy
+367
New +$22.4K 1.05% 19

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Thor Advisors's BMY Position: Q1 2020 in Review

Thor Advisors opened a new position in Bristol-Myers Squibb (BMY) in Q1 2020: 367 shares worth $20K. The stake represents 1.05% of the portfolio and ranks #19 among its holdings.

2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Thor Advisors held 367 shares of Bristol-Myers Squibb worth $20K as of Q1 2020.
  • Bristol-Myers Squibb was a new Thor Advisors position in Q1 2020.
  • Bristol-Myers Squibb made up 1.05% of Thor Advisors's portfolio in Q1 2020, its #19 holding.
  • 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Thor Advisors's 13F filing for Q1 2020, filed 18 May 2020.